• Skip to primary navigation
  • Skip to main content
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

News · February 4, 2020

La Presse: “Laurent Duvernay-Tardif’s knees at their best thanks to a “knee kinesiography with KneeKG” by EMOVI

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

“Unless he is injured during the game on Sunday, Laurent Duvernay-Tardif will be solid on both knees when he blocks to protect Patrick Mahomes, the Kansas City Chiefs quarterback, in order to allow his team to win the Super Bowl; and it is thanks to a technological innovation of a Montreal firm – Emovi – that the Quebec player is today at its peak. (…)

“I then went in search of opinion leaders around the world to make them aware of our KneeKG technology and to test our products in hospitals and research centers,” summarizes Michelle Laflamme. As a result of this, KneeKG became the subject of more than 100 scientific publications. It has been successfully tested on over 10,000 patients and it has been approved by Health Canada and the FDA in the United States.

Last year, Emovi completed a 20 Million-dollar round of financing, of which 14 million was injected by the German fund TVM Life Sciences. Desjardins Venture Capital invested 1 million and Investissement Québec granted a loan of 4.8 million.”

Read more: French (Online) or English (PDF)

YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

Filed Under: News

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact